| Literature DB >> 35214821 |
Antonio Tiberini1, Ariana Manglli1, Anna Taglienti1, Ana Vučurović2, Jakob Brodarič2, Luca Ferretti1, Marta Luigi1, Andrea Gentili1, Nataša Mehle2,3.
Abstract
Tobamovirus species represent a threat to solanaceous crops worldwide, due to their extreme stability and because they are seed borne. In particular, recent outbreaks of tomato brown rugose fruit virus in tomato and pepper crops led to the establishment of prompt control measures, and the need for reliable diagnosis was urged. Another member of the genus, tomato mottle mosaic virus, has recently gained attention due to reports in different continents and its common features with tomato brown rugose fruit virus. In this study, a new real-time RT-PCR detection system was developed for tomato brown rugose fruit virus and tomato mottle mosaic virus on tomato leaves and seeds using TaqMan chemistry. This test was designed to detect tomato mottle mosaic virus by amplifying the movement protein gene in a duplex assay with the tomato brown rugose fruit virus target on the CP-3'NTR region, which was previously validated as a single assay. The performance of this test was evaluated, displaying analytical sensitivity 10-5-10-6-fold dilution for seeds and leaves, respectively, and good analytical specificity, repeatability, and reproducibility. Using the newly developed and validated test, tomato brown rugose fruit virus detection was 100% concordant with previously performed analyses on 106 official samples collected in 2021 from different continents.Entities:
Keywords: Capsicum annum; Solanum lycopersicum; ToBRFV; ToMMV; leaves detection; performance criteria; seeds detections
Year: 2022 PMID: 35214821 PMCID: PMC8878898 DOI: 10.3390/plants11040489
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Primers/probe sets designed on ToMMV reference sequence (NC_022230) and targeting two genome regions (MP and CP).
| Set | Primer/Probe ID | 5′-3′ Sequence | Labeling | Genome Position (nt) | Coding Region |
|---|---|---|---|---|---|
| 1 | ToMMV MWAT Fw | GGAACAGGTTTCTACAACCAGAG | 6124–6146 | CP | |
| ToMMV MWAT Rv | CGTACGCACCACGTGTATTT | 6235–6254 | |||
| ToMMV MWAT Pr1 | TTCTGCGCCAGCGTCCTAAGTAAT | HEX/BHQ1 | 6180–6203 | ||
| 2 | ToMMV MWAT Fw | GGAACAGGTTTCTACAACCAGAG | 6124–6146 | CP | |
| ToMMV MWAT Rv | CGTACGCACCACGTGTATTT | 6235–6254 | |||
| ToMMV MWAT Pr2 | GGCCTGGACTTCTGCGCCA | HEX/BHQ1 | 6171–6189 | ||
| 3 | ToMMV CataAT Fw | CAGCATCTGCTTGGTCGATAA | 5173–5193 | MP | |
| ToMMV CataAT Rv | GGAACGATCTTAAACTGGAACCT | 5255–5277 | |||
| ToMMV CataAT Pr | AATGCAAAGAGCGGATGAAGCGAC | Texas Red/BHQ2 | 5197–5220 | ||
| 4 | ToMMV CSPAT Fw | GGAACAGGTTTCTACAACCAGAG | 6124–6146 | CP | |
| ToMMV CSPAT Rv | CGTACGCACCACGTGTATTT | 6235–6254 | |||
| ToMMV CSPAT Pr | TTCTGCGCCAGCGTCCTAAGTAAT | Texas Red/BHQ2 | 6180–6203 |
All four primers/probe sets were tested versus some other tobamovirus species (TMV, ToMV, TGMV, BPeMV, PMMoV, CGMMV). None of the sets cross-react with TMV, ToMV, TGMV, BPeMV, and PMMoV. However, all three primers/probe sets targeting CP resulted in cross-reaction with CGMMV, whereas no signal was observed for the set targeting the MP region (set 3) (Figure 1).
Figure 1Amplification curves obtained from testing each ToMMV primer/probe set versus ToMMV and non-target tobamovirus species (ToBRFV, TMV, ToMV, TGMV, BPeMV, PMMoV, CGMMV). Cross-reaction of some primers/probe sets was observed only with CGMMV. (Probe labeling: green for HEX, red for Texas Red).
Quantification cycle (Cq) values obtained for each ToMMV and ToBRFV duplex/triplex assay analyzing the same sample set. (HL: healthy leaf; HS: healthy seeds; IL: infected leaf; IS: infected seeds; NAC: negative amplification control; NA: no exponential amplification curve). Results considered as positive are marked in black bold.
| Duplex A | Duplex B | Triplex A | Triplex B | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ToBFRV | ToMMV | ToBRFV | ToMMV | ToBRFV ISHI-Veg | ToMMV | ToBRFV ISHI-Veg | ToMMV | |||
| CP-FAM | CP-HEX | CP-FAM | MP-TexasRed | CP-FAM | MP-HEX | MP-TexasRed | CP-FAM | MP-HEX | CP-TexasRed | |
| HL | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| HS | 37.8 * | NA | NA | NA | 36.0 * | 36.5 * | NA | 35.4 * | 36.1 * | NA |
| ToBRFV IL |
| NA |
| NA |
|
| NA |
|
| NA |
| ToBRFV IS |
| NA |
| NA |
|
| NA |
|
| NA |
| ToMMV IL | NA |
| NA |
| NA | NA |
| NA | NA |
|
| Mixed sample IL |
|
|
|
|
|
|
|
|
|
|
| NAC1 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| NAC2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
* Cq above the Cq threshold considered as negative (no clear exponential amplification curve).
Quantification cycle values obtained for the 10-fold dilution series (in both leaf and seed) tested for ToBRFV (in single or duplex assay) and for ToMMV (in single or duplex assay). In addition, for each assay the E (%) and R2 values were determined and are reported in the table.
| Leaves | Seeds | |||||||
|---|---|---|---|---|---|---|---|---|
| ToBRFVs | ToBRFVd | ToMMVs | ToMMVd | ToBRFVs | ToBRFVd | ToMMVs | ToMMVd | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NA |
| NA |
| NA |
|
| 38.8 * | NA | NA | NA | NA | NA | NA | NA |
|
| 39.4 * | NA | NA | NA | NA | NA | NA | NA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
s—single assay; d—duplex assay; NA—no exponential amplification curve; * Cq above the Cq threshold and considered as negative (no clear exponential amplification curve).
Figure 2Amplification curves obtained from testing the 10-fold dilution series of leaf material (panel (a)) and seed material (panel (b)) in mixed infection ToMMV and ToBRFV, with the selected duplex assay: Duplex B: ToMMV set 3 (probe labeled with Texas Red, curves in red) and ToBRFV M&W (probe labeled with FAM, curves in blue)).
Figure 3Standard curves of the ToBRFV and ToMMV TaqMan® duplex assay in leaf and seed samples obtained from ten-fold serial dilutions. The quantification cycle (Cq) value is plotted against the log of RNA ten-fold serial dilutions. It was possible to adjust a straight line. The value of the slope reported in the straight-line equation allowed for the estimation of the efficiency of the reaction. R2 is a measure of the adjustment to a linear model.
Figure 4TaqMan® assay standard curves obtained in the single and in the duplex assay (for ToMMV on the right and ToBRFV on the left), in leaf (panel (a)) and seed (panel (b)) samples using ten-fold serial dilutions. The quantification cycle (Cq) value is plotted against the log of RNA ten-fold serial dilutions. It was possible to adjust a straight line. The value of the slope reported in the straight-line equation allowed for the estimation of the efficiency of the reaction. R2 is a measure of the adjustment to a linear model.
Results of testing different isolates of non-target tobamoviruses with the duplex ToBRFV and ToMMV assay and the single ToBRFV M&W assay.
| NIB | CREA | |||||||
|---|---|---|---|---|---|---|---|---|
| Single Assay | Duplex | Single Assay | Duplex | |||||
| Virus | Collection | ID | ToBRFV M&W | ToBRFV (Cq) | ToMMV (Cq) | ToBRFV M&W | ToBRFV (Cq) | ToMMV (Cq) |
| BPeMV | DSMZ | BN-4708 | nt | nt | nt | NA | NA | NA |
| nt | nt | nt | NA | NA | NA | |||
| nt | nt | nt | NA | NA | NA | |||
| CGMMV | NIB | NIB V 271 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| CGMMV | NIB | NIB V 320 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| CGMMV | nt | nt | nt | NA | NA | NA | ||
| DSMZ | PV-0375 | nt | nt | nt | NA | NA | NA | |
| nt | nt | nt | NA | NA | NA | |||
| ObPV | DSMZ | PV-1176 | 38.4 * | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ORSV | DSMZ | PV-1048 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| PaMMV | DSMZ | PV-0606 (2020) ** |
|
|
| nt | nt | nt |
|
|
|
| nt | nt | nt | |||
|
|
|
| nt | nt | nt | |||
| PaMMV | DSMZ | PV-0606 (2021) ** |
|
|
| nt | nt | nt |
|
|
|
| nt | nt | nt | |||
|
|
|
| nt | nt | nt | |||
| PMMoV | CREA | CREA-552 | nt | nt | nt | NA | NA | NA |
| nt | nt | nt | NA | NA | NA | |||
| nt | nt | nt | NA | NA | NA | |||
| PMMoV | DSMZ | PV-0165 | nt | nt | nt | NA | NA | NA |
| nt | nt | nt | NA | NA | NA | |||
| nt | nt | nt | NA | NA | NA | |||
| RMV | DSMZ | PV-0145 |
|
| NA | nt | nt | nt |
|
|
| NA | nt | nt | nt | |||
|
|
| NA | nt | nt | nt | |||
| SFBV | DSMZ | PV-1058 | NA | NA | NA | nt | nt | nt |
| NA | 38.2 * | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| SHMV | DSMZ | PV-0156 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ToMV | NIB | NIB V 036 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ToMV | NIB | NIB V 049 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ToMV | NIB | NIB V 072 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ToMV | NIB | NIB V 104 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| ToMV | DSMZ | PV-0141 | nt | nt | nt | NA | NA | NA |
| nt | nt | nt | NA | NA | NA | |||
| nt | nt | nt | NA | NA | NA | |||
| TMGMV | DSMZ | PV-0124 | NA | NA | NA | NA | NA | NA |
| NA | NA | NA | NA | NA | NA | |||
| NA | NA | NA | NA | NA | NA | |||
| TMV | NIB | NIB V 037 | NA | NA | NA | nt | nt | nt |
| NA | NA | NA | nt | nt | nt | |||
| NA | NA | NA | nt | nt | nt | |||
| TMV | DSMZ | PV-1252 | nt | nt | nt | NA | NA | NA |
| nt | nt | nt | NA | NA | NA | |||
| nt | nt | nt | NA | NA | NA | |||
| TMV | DSMZ | PV-0137 | NA | NA | NA | NA | NA | NA |
| 38.5* | NA | NA | NA | NA | NA | |||
| NA | NA | NA | NA | NA | NA | |||
| TMV | DSMZ | PV-0943 | NA | NA | NA | NA | NA | NA |
| NA | NA | NA | NA | NA | NA | |||
| NA | NA | NA | NA | NA | NA | |||
| YMoV | DSMZ | PV-0527 | NA | NA | NA | NA | NA | NA |
| NA | NA | NA | NA | NA | NA | |||
| NA | NA | NA | NA | NA | NA | |||
NA—no exponential amplification curve; nt-not tested; * Cq above the Cq threshold and considered as negative (no clear exponential amplification curve); ** two batches of isolate were tested (one purchased from DSMZ in 2020 and one in 2021).
Results of testing different isolates of ToMMV and ToBRFV with the duplex ToBRFV and ToMMV assay and the single ToBRFV M&W assay.
| Single | Duplex | ||||
|---|---|---|---|---|---|
| Virus | Collection | ID | ToBRFV M&W (Cq) | ToBRFV M&W (Cq) | ToMMV (Cq) |
| ToMMV | DSMZ, DE | PV-1267 | 36.9 * | NA |
|
| 38.9 * | NA |
| |||
| 37.6 * | NA |
| |||
| ToMMV | IBMCP; SP | S1 | nt | NA |
|
| nt | NA |
| |||
| nt | NA |
| |||
| ToMMV | IBMCP; SP | S2 | nt | NA |
|
| nt | NA |
| |||
| nt | NA |
| |||
| ToBRFV | CREA, IT | MR50 |
|
| NA |
| ToBRFV | Volcani center; IS | S21 | nt |
| NA |
| nt |
| NA | |||
| nt |
| NA | |||
| ToBRFV | Volcani center; S | S22 | nt |
| NA |
| nt |
| NA | |||
| nt |
| NA | |||
NA—no exponential amplification curve; nt-not tested; * Cq above the Cq threshold and considered as negative (no clear exponential amplification curve). DE: Germany; IS: Israel; IT: Italy; SP: Spain.
Results of testing medium and low concentration of targets and negative amplification controls with the duplex ToBRFV and ToMMV assay at NIB and at CREA on different days using different instruments, operators, and reagents.
| ToBRFV (Cq) | ToMMV (Cq) | ToBRFV (Cq) | ToMMV (Cq) | ToBRFV (Cq) | ToMMV (Cq) | ToBRFV (Cq) | ToMMV (Cq) | ToBRFV (Cq) | ToMMV (Cq) | ToBRFV (Cq) | ToMMV (Cq) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Run ID | 1 | 2 | 3 | 4 | 5 | 6 | |||||||
| NIB | ToBRFV PC1 |
| NA |
| NA |
| NA |
| NA |
| NA |
| NA |
| ToBRFV PC2 |
| NA |
| NA |
| NA |
| NA |
| NA |
| NA | |
| ToMMV PC1 | NA |
| NA |
| NA |
| NA |
| NA |
| NA |
| |
| ToMMV PC2 | NA |
| NA |
| NA |
| NA |
| NA |
| NA |
| |
| NAC1 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| NAC2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| CREA | ToBRFV PC1 |
| NA |
| NA |
| NA |
| NA | nt | nt | nt | nt |
| ToBRFV PC2 |
| NA |
| NA |
| NA |
| NA | nt | nt | nt | nt | |
| ToMMV PC1 | NA |
| NA |
| NA |
| NA |
| nt | nt | nt | nt | |
| ToMMV PC2 | NA |
| NA |
| NA |
| NA |
| nt | nt | nt | nt | |
| NAC1 | NA | NA | NA | NA | NA | NA | NA | NA | nt | nt | nt | nt | |
| NAC2 | NA | NA | NA | NA | NA | NA | NA | NA | nt | nt | nt | nt | |
NA—no exponential amplification curve; nt-not tested; NAC—negative amplification control; PC1—positive control with medium target (ToBRFV/ToMMV) concentration; PC2—positive control with low target (ToBRFV/ToMMV) concentration.